Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
NCT06352359
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
ONC-841
Sponsor
OncoC4, Inc.